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1 Background: Despite clinical intervention, people with chronic inflammatory 2 demyelinating polyneuropathy (CIDP) experience difficulties in gait and balance on a 3 daily basis. However, the effects on these variables of a tailored home based 4 exercise programme for this population have not been investigated. This case series 5 aims to investigate the effects of a home based tailored exercise programme on gait 6 and balance in people with CIDP. progressive autoimmune disease of the peripheral nervous system. Yearly up to 3 approximately 1.6 per 100,000 of the UK population contracts the disease, whereas 4 8.9/100,000 people are living with CIDP [1] .
5
Characterized by distal and proximal weakness of the upper and lower limbs, the 6 disease also presents with sensory impairments such as balance disturbance, 7 numbness of the hands and feet and areflexia [2] . However the presentation of the 8 symptoms for each individual varies greatly, therefore the population is very 9 heterogeneous. In addition, motor defects associated with the disorder may lead to 10 abnormalities in gait, and the long term nature of this condition can lead to 11 impairment in both psychological and social functioning.
12
Pharmaceutical approaches have shown the condition responds to treatment with term usage [7] . In addition, maintaining movement and balance throughout the low-intensity and high-intensity ambulatory rehabilitation programme found a clinical 7 improvement which favoured the high-intensity programme in GBS patients [9] . these practices were applied to CIDP patients.
15
There has been little research over the years providing information on the functional 16 impact of exercise in CIDP, this is partly due to the rarity of the condition. The fatigue and mental states such as anxiety and depression in people with CIDP [14] .
21
Whilst these are important factors in CIDP, as they can significantly disrupt an Exclusion criteria included; no detectable leg weakness, inadequate vision or hearing 10 to receive instructions, diagnosis of multifocal motor neuropathy, any significant 11 relevant comorbidity e.g. significant arthritis, cardiac failure, cervical myelopathy 12 which might affect gait, the need to use ambulatory aids during walking and any 13 inconsistent IVIG use throughout the study. form. An Overall Neuropathies Limitation Scale (ONLS) assessment was carried out 17 prior to the first assessment. The ONLS score was calculated by adding the arm 18 score to the leg score and ranged from 0 (no disability) to 12 (maximum disability).
19

Protocol
20
This clinical case series was based on an AAABBBAAAA design; participants were 21 assessed three times prior to, three times during, three times post intervention and The EQ-5D-5L presents a range of 5 sub sections which include Mobility, Self-care, Balance scale marked a genuine change in function for a participant [22] and this cut 20 off point was used in this study.
21
For the complete patient group average scores were taken from the 3 assessments 22 in the pre-intervention assessment phases and the 3 assessments in the post- 
Results
22
Demographics
23
Seven participants (5 females, 2 males), participated in this study. One participant 1 withdrew from the study during the pre-intervention phase for personal reasons. 3). This latter participant also commented that she was able to pick up her favourite be noted that all of the participants continued all or part of their exercises after the 10 intervention was completed.
11
Group results
12
As a patient group, both of the clinical outcomes for the 10 MWT and the Berg FSS and the EQ-5D-5L, however these changes were not statistically significant 17 (Table 2) .
18
Insert Table 2 here During the intervention a varied response was seen regarding walking speeds and be an effect of the exercise intervention, however it could also be explained by the 21 masking of the additional gains of the faster walking participants as they were near In line with Graham et al [14] our participants also reported to be less fatigued, 5 although this was not significant. A study encompassing more participants and 6 perhaps a longer or more intense intervention could show a significant result. The 7 reduced fatigue levels in this study could be caused by increased strength levels due 8 to the intervention, but could also be explained by the possibility that participants 9 were less depressed due to improved Quality of Life, became less depressed, 10 became less anxious of the assessments over time or by the day to day variability 11 seen in this disease [14] . Although the latter is possible this study used an average 12 of three assessments and assessed the participants at set time points to limit this 13 effect.
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Study limitations
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The MCID values used in this study were taken from the literature for older people to identify which aspects facilitate this change. We would like to thank all the participants involved and Glasshouse Appeal 10 (registered charity 1106441) for funding this study. Funding: Glasshouse Appeal (registered charity 1106441) funded this study.
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